The DBV Technologies internet site is the right place to start to have a look at what may be the future of allergy treatment. Allergies negatively affect the lives of tens, if not hundreds of millions of people around the world. From cow’s milk to peanut, seafood to eggs, many very common foods can cause allergies with reactions of varying severity.
DBV-Technologies has been developing a solution to allergies that’s both hi-tech and simple. It’s called the Viaskin platform, and you can click here to find out more about how it works and how it’s made. Viaskin is composed of an adhesive crown, a titanium backing and very small quantities of an allergen, which is sprayed onto the backing by an electrospray (pictured below). DBV-Technologies is aiming to increase the production of these patches with the introduction of new machine technology. The allergen is transferred from the patch to the patient by a very simple method. It involves the creation of what is called a condensation chamber between the skin and the patch centre. This creates an accumulation of water which solubilizes the allergen, enabling it to be absorbed into the skin.